ScholarIQanswers from OpenAlex & ORCID
Axel Bex
ResearcherPublications, citations & collaboration network
Axel Bex is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Axel Bex have?
ScholarIQindexed works
Axel Bex has 612 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Axel Bex have?
ScholarIQcitation count
Axel Bex has 25,639 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Axel Bex?
ScholarIQh-index
Axel Bex has an h-index of 67 in OpenAlex.
What is the i10-index of Axel Bex?
ScholarIQi10-index
Axel Bex has an i10-index of 254 in OpenAlex.
What is the ORCID of Axel Bex?
ScholarIQorcid
The ORCID for Axel Bex is on the source record.
What is the OpenAlex record for Axel Bex?
ScholarIQopenalex
The OpenAlex for Axel Bex is on the source record.
What are the most-cited papers on Axel Bex?
ScholarIQmost cited works
Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
T. Powles, Laurence Albigès, Axel Bex, Éva Compérat, Viktor Grünwald, Ravindran Kanesvaran, H. Kitamura, R. McKay, Camillo Porta, G. Procopio, Manuela Schmidinger, Cristina Suárez, Jeremy Yuen‐Chun Teoh, Guillermo de Velasco, Matthew R. Young, Silke Gillessen
European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era
María J. Ribal, Philip Cornford, Alberto Briganti, Thomas Knoll, Stavros Gravas, Marek Babjuk, Christopher Harding, Alberto Breda, Axel Bex, Jens Rassweiler, Ali Serdar Gözen, Giovannalberto Pini, Evangelos Liatsikos, Gianluca Giannarini, Alex Mottrie, Ramnath Subramaniam, Nikolaos Sofikitis, Bernardo Rocco, Li-Ping Xie, J. Alfred Witjes, Nicolas Mottet, Börje Ljungberg, Morgan Rouprêt, M. Pilar Laguna, Andrea Salonia, Gernot Bonkat, Bertil Blok, Christian Türk, Christian Radmayr, Noam D. Kitrey, Daniel Engeler, Nicolaas Lumen, Oliver W. Hakenberg, Nick Watkin, Rizwan Hamid, Jonathon Olsburgh, Julie Darraugh, Robert P. Shepherd, Emma Jane Smith, Christopher R. Chapple, Arnulf Stenzl, Hendrik Van Poppel, Manfred Wirth, Jens Sønksen, James N’Dow
Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial
Robert J. Motzer, Paul Russo, Viktor Grünwald, Yoshihiko Tomita, Bogdan Żurawski, Omi Parikh, Sebastiano Buti, Philippe Barthélémy, Jeffrey C. Goh, Dingwei Ye, Alejo Lingua, Jean‐Baptiste Lattouf, Laurence Albigès, Saby George, Brian Shuch, Jeffrey A. Sosman, Michael Staehler, Sergio Vázquez Estévez, Burçin Şimşek, Julia Spiridigliozzi, Aleksander Chudnovsky, Axel Bex